HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Constancio Gonzalez Selected Research

Dopamine Agonists (Dopamine Agonist)

12/2008An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Constancio Gonzalez Research Topics

Disease

19Hypoxia (Hypoxemia)
10/2019 - 08/2002
3Hypercapnia
10/2019 - 08/2009
3Insulin Resistance
04/2015 - 01/2012
3Hypertension (High Blood Pressure)
10/2014 - 01/2012
3Hyperventilation
01/2014 - 08/2009
2Ganglion Cysts (Ganglion)
10/2019 - 12/2012
2Chronic Obstructive Pulmonary Disease (COPD)
01/2014 - 01/2012
2Acidosis
08/2009 - 11/2006
1Obesity
10/2014
1Metabolic Diseases (Metabolic Disease)
01/2014
1Hyperinsulinism (Hyperinsulinemia)
08/2013
1Inflammation (Inflammations)
08/2012
1Weight Gain
01/2012

Drug/Important Bio-Agent (IBA)

5Neurotransmitter Agents (Neurotransmitter)IBA
10/2019 - 08/2002
4Adenosine (Adenocard)FDA LinkGeneric
10/2019 - 12/2008
4Caffeine (No Doz)FDA LinkGeneric
04/2015 - 01/2012
4Insulin (Novolin)FDA Link
10/2014 - 01/2012
4CatecholaminesIBA
04/2012 - 11/2006
3SmokeIBA
01/2014 - 12/2011
3Oxygen (Dioxygen)IBA
12/2012 - 08/2002
2Purinergic P1 Receptors (Adenosine Receptor)IBA
04/2015 - 12/2012
2LipidsIBA
10/2014 - 12/2013
2Dopamine (Intropin)FDA LinkGeneric
12/2012 - 01/2012
2Glutathione (Reduced Glutathione)IBA
01/2012 - 03/2004
1Purinergic P2 Receptors (ADP Receptor)IBA
10/2019
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2019
1NestinIBA
10/2019
1Adenosine Triphosphate (ATP)IBA
10/2019
1AminesIBA
04/2015
15- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
04/2015
1SodiumIBA
04/2015
1N- (4- cyanophenyl)- 2- (4- (2,3,6,7- tetrahydro- 2,6- dioxo- 1,3- dipropyl- 1H- purin- 8- yl)- phenoxy)acetamideIBA
04/2015
1XanthineIBA
04/2015
11,3-dipropyl-8-cyclopentylxanthineIBA
04/2015
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2015
1LeptinIBA
10/2014
1Glucose (Dextrose)FDA LinkGeneric
10/2014
1CholesterolIBA
10/2014
1Triglycerides (Triacylglycerol)IBA
10/2014
1Blood Proteins (Serum Proteins)IBA
01/2014
1GasesIBA
01/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1CytokinesIBA
01/2014
1ElementsIBA
12/2013
1Nifedipine (Adalat)FDA LinkGeneric
04/2012
1PlasticsIBA
01/2012
1S(8)IBA
01/2012
1antineoplaston A10 (A 10)IBA
01/2012
1erythromycin propionate-N-acetylcysteinateIBA
01/2012
1Carvedilol (Coreg)FDA LinkGeneric
01/2012
1Cyclic AMP (AMP, Cyclic)IBA
01/2012
1Nonesterified Fatty Acids (NEFA)IBA
01/2012
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2012
1Serotonin (5 Hydroxytryptamine)IBA
01/2012
1Sucrose (Saccharose)IBA
01/2012
1NADPH Oxidases (NAD(P)H oxidase)IBA
10/2011
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
10/2011
1RotenoneIBA
10/2011
1Caveolin 1IBA
10/2011
1CeramidesIBA
10/2011
1acetovanillone (apocynin)IBA
10/2011
1dihydroethidiumIBA
10/2011
1Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
10/2011
1Tetraethylammonium (Tetraethylammonium Bromide)IBA
09/2009
1CalciumIBA
09/2009
1AcidsIBA
09/2009
1iberiotoxinIBA
09/2009
1Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
09/2009
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
08/2009
1IonomycinIBA
08/2009
19-(tetrahydro-2-furyl)-adenineIBA
08/2009
1Dopamine Agonists (Dopamine Agonist)IBA
12/2008
1Protein Isoforms (Isoforms)IBA
07/2007
1ErythropoietinFDA Link
08/2002

Therapy/Procedure

1Therapeutics
01/2014
1Denervation
08/2013